These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 559543

  • 1. Lethal and sublethal effects of hydroxyurea in relation to drug concentration and duration of drug exposure in sarcoma 180 in vitro.
    Ford SS, Shackney SE.
    Cancer Res; 1977 Aug; 37(8 Pt 1):2628-37. PubMed ID: 559543
    [Abstract] [Full Text] [Related]

  • 2. Kinetic effects of sangivamycin in sarcoma 180 in vitro.
    Ritch PS, Glazer RI, Cunningham RE, Shackney SE.
    Cancer Res; 1981 May; 41(5):1784-8. PubMed ID: 7214345
    [Abstract] [Full Text] [Related]

  • 3. Increased relative effectiveness of doxorubicin against slowly proliferating sarcoma 180 cells after prolonged drug exposure.
    Ritch PS, Occhipinti SJ, Skramstad KS, Shackney SE.
    Cancer Treat Rep; 1982 May; 66(5):1159-68. PubMed ID: 7083218
    [Abstract] [Full Text] [Related]

  • 4. Schedule optimization of hydroxyurea and 1-beta-D-arabinofuranosylcytosine in sarcoma 180 in vitro.
    Shackney SE, Ford SS, Occhipinti SJ, Ritch PS, Riccardi R, Erickson BW.
    Cancer Res; 1982 Nov; 42(11):4339-47. PubMed ID: 7127279
    [No Abstract] [Full Text] [Related]

  • 5. Schedule-dependent synergism of combinations of hydroxyurea with adriamycin and 1-beta-D-arabinofuranosylcytosine with adriamycin.
    Ritch PS, Occhipinti SJ, Cunningham RE, Shackney SE.
    Cancer Res; 1981 Oct; 41(10):3881-4. PubMed ID: 7284997
    [Abstract] [Full Text] [Related]

  • 6. Correlations between the DNA content distribution and tritiated thymidine studies in relation to population size in sarcoma 180 in vitro.
    Shackney SE, Ford SS.
    Cancer Res; 1974 Jun; 34(6):1401-7. PubMed ID: 4857014
    [No Abstract] [Full Text] [Related]

  • 7. Schedule dependence of vincristine lethality in Sarcoma 180 cells following partial synchronization with hydroxyurea.
    Mujagic H, Conger BM, Smith CA, Occhipinti SJ, Schuette WH, Shackney SE.
    Cancer Res; 1983 Aug; 43(8):3598-603. PubMed ID: 6861132
    [Abstract] [Full Text] [Related]

  • 8. The effects of counting threshold and emulsion exposure duration on the percent-labeled mitosis curve and their implications for cell cycle analysis.
    Shackney SE, Ford SS, Wittig AB.
    Cancer Res; 1973 Nov; 33(11):2726-31. PubMed ID: 4795901
    [No Abstract] [Full Text] [Related]

  • 9. In vivo synchronization of murine sarcoma 37 ascites tumor cells by use of hydroxyurea.
    Matthews RH, Dewar D, Webb TE.
    Physiol Chem Phys; 1976 Nov; 8(2):151-5. PubMed ID: 790422
    [Abstract] [Full Text] [Related]

  • 10. Mathematic models of cell synchrony and drug scheduling.
    Valleron Aj.
    Cancer Treat Rep; 1976 Dec; 60(12):1899-911. PubMed ID: 1026345
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Incorporation of H3-thymidine into the DNA of cells of surviving slices of transplantable tumors, sensitive and resistant to sarcolysine].
    Merkulov MF, Shelaputina ZF, Iavorskaia NP, Leskova SG.
    Farmakol Toksikol; 1970 Dec; 33(6):715-23. PubMed ID: 5518494
    [No Abstract] [Full Text] [Related]

  • 13. Ionizing radiations and the cell cycle.
    Tolmach LJ, Weiss BG, Hopwood LE.
    Fed Proc; 1971 Dec; 30(6):1742-51. PubMed ID: 4256572
    [No Abstract] [Full Text] [Related]

  • 14. Modification by caffeine of acute cytotoxic response of cultured L5178Y cells to hydroxyurea treatment.
    Sawecka J, Gołos B, Malec J.
    Neoplasma; 1987 Dec; 34(4):369-77. PubMed ID: 3658045
    [Abstract] [Full Text] [Related]

  • 15. Use of flow microfluorometry in detailed analysis of effects of chemical agents on cell cycle progression.
    Tobey RA, Crissman HA.
    Cancer Res; 1972 Dec; 32(12):2726-32. PubMed ID: 4118766
    [No Abstract] [Full Text] [Related]

  • 16. Effects of double and multiple doses of hydroxyurea on mouse duodenum and mammary tumors.
    Dethlefsen LA, Sorensen SP, Riley RM.
    Cancer Res; 1975 Mar; 35(3):694-9. PubMed ID: 1116130
    [Abstract] [Full Text] [Related]

  • 17. Evidence for the lack of relationship between inhibition of nucleic acid synthesis and cytotoxicity of adriamycin.
    Siegfried JM, Sartorelli AC, Tritton TR.
    Cancer Biochem Biophys; 1983 Mar; 6(3):137-42. PubMed ID: 6850549
    [Abstract] [Full Text] [Related]

  • 18. DNA synthesis in multiple myeloma cells following cell cycle-nonspecific chemotherapy.
    Alberts DS, Golde DW.
    Cancer Res; 1974 Nov; 34(11):2911-4. PubMed ID: 4424360
    [No Abstract] [Full Text] [Related]

  • 19. Effects of vincristine on cell survival, cell cycle progression, and mitotic accumulation in asynchronously growing Sarcoma 180 cells.
    Mujagic H, Chen SS, Geist R, Occhipinti SJ, Conger BM, Smith CA, Schuette WH, Shackney SE.
    Cancer Res; 1983 Aug; 43(8):3591-7. PubMed ID: 6861131
    [Abstract] [Full Text] [Related]

  • 20. Differential cytotoxicity between transformed and normal human cells with combinations of aminonucleoside and hydroxyurea.
    Bradley MO, Kohn KW, Sharkey NA, Ewig RA.
    Cancer Res; 1977 Jul; 37(7 Pt 1):2126-31. PubMed ID: 861939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.